Add BrightSurf on Google Email

Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination

Researchers found that farm-raised tilapia has very low levels of beneficial omega-3 fatty acids and high levels of omega-6 fatty acids. This combination may be detrimental to individuals with heart disease, arthritis, asthma, and other conditions. The study highlights the importance of balancing omega-6 and omega-3 fatty acid intake.

SourceAtrium Health Wake Forest Baptist·JournalJournal of the American Dietetic Association·DateJul 8, 2008

Gender differences and heart disease

Researchers found that women derive less benefit from high-blood-pressure-lowering drugs than men for reducing left-ventricular hypertrophy, a marker for future heart disease. This may explain why women are at greater risk for heart disease later in life despite similar blood pressure reduction.

SourceNewYork-Presbyterian·JournalHYPERTENSION·DateJul 1, 2008

Mayo Clinic: Heart patients fare better in 3-year program

Researchers at Mayo Clinic found that heart patients who met regularly with cardiac 'disease managers' for three years had better control of risk factors and lower death rates. The approach demonstrated clear clinical benefits, including improved cholesterol levels, blood pressure, and medication compliance.

SourceMayo Clinic·JournalJournal of Cardiopulmonary Rehabilitation and Prevention·DateJun 4, 2008

Increased screening may better predict those at higher risk for heart disease, researchers report

Researchers found that adding noninvasive imaging to risk-assessment protocols increased the number of people classified as high risk for heart disease. This approach is proposed by the Screening for Heart Attack Prevention and Education task force, which aims to identify more patients who could benefit from cholesterol-lowering therapy.

SourceUT Southwestern Medical Center·JournalArchives of Internal Medicine·DateMay 26, 2008

Major discovery in the treatment of aortic valve stenosis

A recent study published in the British Journal of Pharmacology has made a significant breakthrough in treating aortic valve stenosis, a common form of heart valve disease. The experimental treatment, which raises high-density lipoproteins (HDL), showed promising results, including reduced aortic valve narrowing and calcifications.

SourceUniversity of Montreal·JournalBritish Journal of Pharmacology·DateApr 18, 2008